Researcher in Residence, Cancer Experience, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Witham Road, Sheffield, S10 2SJ, England.
Oncology Haematology Business Unit, National Partnership Manager, Bristol Myers Squibb, Buckinghamshire, UK.
Support Care Cancer. 2023 Aug 30;31(9):541. doi: 10.1007/s00520-023-08005-w.
In response to the COVID-19 pandemic, virtual consultations were introduced rapidly across cancer services. This created a particular set of challenges for systemic anticancer therapy services, where patients have frequent, regular appointments to support decision-making regarding treatment. This study explores the experiences of staff who provide these consultations to understand the implications for patients, staff, and services.
A mixed-methods approach was utilized using electronic surveys containing open text and structured responses and a focus group. The survey was sent to all staff in a regional cancer center who carried out consultations with patients receiving Systemic Anticancer Therapy. Data collection took place between October 2020 and January 2021. Open text responses were analyzed using framework techniques.
Thirty-three medical, nursing, and pharmacy staff completed the survey, and 21 attended the focus group. Staff experiences were described within a framework of risk, loss, and gain. Virtual consultations had clinical consequences for the accuracy of assessments and communication with patients. Criteria for using virtual or in-person appointments were identified along with organizational systems and processes that influenced effectiveness and safety. Concerns were raised regarding role satisfaction and use of clinical skills.
The study provides new insights into the experiences and concerns of staff associated with virtual appointments. The primary purpose of consultation in systemic anticancer therapy services is to support decision-making regarding treatment, and the study identified obstacles to achieving this alongside possible criteria for determining when in-person or virtual consultations may be appropriate.
为应对 COVID-19 大流行,癌症服务领域迅速引入了虚拟咨询。这给系统抗癌治疗服务带来了一系列特殊的挑战,因为这些患者需要定期频繁就诊,以支持治疗决策。本研究旨在探索提供这些咨询服务的员工的经验,以了解其对患者、员工和服务的影响。
采用混合方法,使用包含开放式文本和结构化回复的电子调查问卷和焦点小组。该调查面向在区域癌症中心为接受系统抗癌治疗的患者进行咨询的所有工作人员发送。数据收集于 2020 年 10 月至 2021 年 1 月期间进行。采用框架技术对开放式文本回复进行分析。
共有 33 名医疗、护理和药剂师工作人员完成了调查,其中 21 人参加了焦点小组。工作人员的经验被描述为风险、损失和收益框架内。虚拟咨询对评估的准确性和与患者的沟通产生了临床影响。确定了使用虚拟或面对面预约的标准,以及影响有效性和安全性的组织系统和流程。人们对角色满意度和临床技能的使用提出了担忧。
本研究提供了有关与虚拟预约相关的员工经验和关注点的新见解。系统抗癌治疗服务咨询的主要目的是支持治疗决策,研究确定了实现这一目标的障碍,以及确定何时适合进行面对面或虚拟咨询的可能标准。